Drawing from Chapple’s recent position as General Manager at Cognizant’s Life Sciences BPO practice, Quanticate will leverage his business development leadership and extensive knowledge of the clinical CRO space, including full service CROs, specialist BPOs and solutions expertise in the pharmaceutical, biotechnology and medical device sectors.

“Daniel’s customer-focused orientation, self-awareness, and strong business acumen skills make him a good fit as part of our executive management team,” said Underwood. “This is an exciting time at Quanticate as we are growing our operations in the US and India to support our teams already in place in the UK, Poland and South Africa.  Daniel will help to streamline our approach to working across these regions to support our clients at the functional and task level due to his strong background.”

Through the use of technology coupled with highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts, Chapple will further focus the Centralized Clinical Data Sciences solution which will help leverage the data required to secure approvals and market new products.  This approach supports the growing requirement of the life sciences industry to reduce timelines, minimize regulatory delays and reduce costs associated with the drug development process.

“Our team has incredible amounts of experience and many of our staff are recognized experts in the industry,” said Chapple.  “As the expectations of regulatory bodies continue to rise, pharmaceutical companies are under intense pressure to optimize costs through increasing productivity, lowering internal costs and implementing strategic partnerships.  It is not just about using the lowest cost people, it is also ensuring the overall drug development cost is optimal when taking into account productivity, over-sight and expertise.   By providing faster access to data, developing more efficient study design approaches and offering complete data reviews across programs that may include many studies over many years, Quanticate plays a key role in supporting its clients.”

Prior to Quanticate, Chapple served in leadership positions at Cognizant, ICON Clinical Research and MDS Pharma Services

About Quanticate

Quanticate, with headquarters in the UK and USA, is a specialist Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. We provide very efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain functions in their entirety.

Clinical trial management services include scalable on-site and off-site data management, statistical consultancy, statistical programming & analysis, medical writing and pharmacovigilance.  Our staff recruitment arm, "Quanticate People,” helps Sponsors find all types of permanent and contract staff.   For more news and information, visit www.quanticate.com

“Based on Quanticate’s 10-plus years of outsourcing and extensive clinical trial experience, this is an advancement in outsourcing that Quanticate is well placed to deliver. It has benefits in trial design and provides an efficient use of database design. Our outsourcing model can also leverage the latest technologies in cloud computing as well as ensure global regulatory compliance,” said David Underwood, CEO of Quanticate.

Centralized Clinical Data Sciences is the optimal outsourcing model because it further develops strategic alliances and functional service provision and allows for easy combining of data from different studies within and across Phases.

In addition to the new outsourcing model, Quanticate is launching a Statistical Consultancy Helpdesk, an online resource that will provide easy access to expert Statistical Consultancy. Either via a dedicated phone line or the Internet, customers will be able to access the helpdesk with ease.

“This is a new concept in Consultancy and I am very excited that we can provide instant access to our experts. It is quick, easy to use, and will help our customers get the answers they need more rapidly,” said Karen Ooms, Head of Statistical Consultancy at Quanticate.

About Quanticate

Quanticate, with headquarters in the UK and USA, is a specialist Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. We provide very efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain functions in their entirety.

Clinical trial management services include scalable on-site and off-site data management, statistical consultancy, statistical programming & analysis, medical writing and pharmacovigilance.  Our staff recruitment arm, "Quanticate People," helps Sponsors find all types of permanent and contract staff.   For more information, visit www.quanticate.com.

PSI (Statisticians in the Pharmaceutical Industry) was set up over 30 years ago to promote and lead statistical thinking in the Pharmaceutical industry. As a non-profit making organization with over 1000 members, it runs several training courses, one day meetings and a 3 day conference every year as well as providing support to the education sector. In addition, its own peer-reviewed journal, Pharmaceutical Statistics, has gained an impressive following in its 10 year existence. Such an organization requires support from its members to help with the day-to-day running of PSI. Quanticate has for many years provided such support – through committee member involvement (publications and training committees to name but two) and board level support (contracts, membership). Quanticate congratulates and wishes Katherine Hutchinson (Head of Consultancy at Quanticate) all the best in her role chairing PSI in the year ahead.

If you have any questions about our involvement at the conference please contact us at enquiries@quanticate.com

Read this article, the first in a series on oncology studies.

The data and their interpretation are the final product of clinical trials and their importance cannot be overstated. This is our focus, and many companies, particularly those with oncology products, centralize their data and reporting with Quanticate because of the efficiencies it brings.